These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 15277277)

  • 1. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
    Chang JT; Katzka DA
    Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Barrett's esophagus.
    Spechler SJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?
    Dellon ES; Shaheen NJ
    J Clin Oncol; 2005 Jul; 23(20):4478-82. PubMed ID: 16002837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroesophageal reflux and adenocarcinoma of the esophagus.
    Heath EI; Holbrook JT; Forastiere AA
    N Engl J Med; 1999 Aug; 341(7):536-7; author reply 537-8. PubMed ID: 10447438
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of esophageal adenocarcinoma.
    Pera M; Manterola C; Vidal O; Grande L
    J Surg Oncol; 2005 Dec; 92(3):151-9. PubMed ID: 16299786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and molecular biology of Barrett esophagus.
    Casson AG; Williams L; Guernsey DL
    Semin Thorac Cardiovasc Surg; 2005; 17(4):284-91. PubMed ID: 16428034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
    Lassen A; Hallas J; de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction.
    Eng C; Spechler SJ; Ruben R; Li FP
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):397-9. PubMed ID: 8348064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
    Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
    Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
    Shaheen N; Ransohoff DF
    JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's esophagus in patients with gastroesophageal reflux disease. Medical therapy or antireflux surgery?
    Klaus A; Mühlmann G; Kirchmayr W; Weiss H; Wetscher GJ
    Minerva Chir; 2002 Aug; 57(4):397-402. PubMed ID: 12145570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
    Lagergren J; Bergström R; Lindgren A; Nyrén O
    N Engl J Med; 1999 Mar; 340(11):825-31. PubMed ID: 10080844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for esophageal cancer development.
    Falk GW
    Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD?
    Lagergren J
    Gastrointest Endosc; 2008 Nov; 68(5):856-8. PubMed ID: 18984099
    [No Abstract]   [Full Text] [Related]  

  • 18. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
    Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
    J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.
    Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.